Scopio Labs is an advanced digital microscopy company that develops breakthroughs in digital microscopy that help improve accuracy, efficiency and accessibility wherever the microscope plays a role in the diagnostic process.
Scopio Labs has designed and built a computational microscope and developed a proprietary diagnostics platform to enable quality microscopic analysis.
Scopio Labs was founded in 2015 by Itai Hayut and Erez Na’aman. The company is headquartered in Tel Aviv, Israel, with an office in Roseland, New Jersey.
Scopio Labs is propelling microscopy into the digital age. Its platform automates the imaging of full microscopy samples into uniquely high resolution digital scans using cutting-edge computational photography techniques.
The Scopio microscope captures and digitizes full slide microscopy data. Using advanced computational photography techniques to reconstruct data, Scopio offers an automated digital microscopy scanning system with uniquely high resolution and quality images.
Scopio also built and integrated end-to-end AI and remote consultation solutions for large and small labs and hospitals across the continuum of care to improve diagnostic processes while reducing turn-around time.
Scopio Labs is backed by Olive Tree Ventures, Aurum Ventures, OurCrowd, LR group and others. The company raised $16M in a Series B round on Apr 28, 2020. This brings Scopio's total funding to $30M to date.